Content area
Full Text
The American Association for Cancer Research issued the following news release:
The American Association for Cancer Research congratulates Raymond N. DuBois, M.D., Ph.D., on his appointment as executive director of The Biodesign Institute at Arizona State University (ASU) in Tempe, Ariz. He will begin his new role on Dec. 1.
DuBois will also hold the Dalton Chair in ASU's School of Health Solutions with joint appointments in chemistry and biochemistry, and will have a joint appointment at the Mayo Clinic where he will co-lead the cancer prevention program.
An internationally renowned physician-scientist, DuBois served as provost and executive vice president of The University of Texas MD Anderson Cancer Center in Houston since 2007. He also held appointments as professor of cancer biology and cancer medicine. At MD Anderson he was responsible for developing and overseeing research strategy, faculty, the School of Health Professions, graduate education programs and initiatives, and Global Academic Programs.
His groundbreaking research has helped increase our understanding of colorectal cancer, as he and colleagues were the first to discover that colorectal cancers over-expressed the enzyme cyclo-oxygenase-2 (COX-2) and that blocking or inhibiting COX-2 enzymes would shrink colorectal tumors. This research led to clinical trials involving Celebrex, a nonsteroidal anti-inflammatory drug used to treat arthritis, as a novel treatment for precancerous colorectal polyps.
"Dr. DuBois' broad...